Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2017

01-03-2017 | Letter to the Editor

Feasibility of Bariatric Surgery in the HIV-Infected Patients

Authors: Radwan Kassir, Eve Huart, Olivier Tiffet, Anne Frésard, Fréderic Lucht, Amandine Gagneux-Brunon, Elisabeth Botelho-Nevers

Published in: Obesity Surgery | Issue 3/2017

Login to get access

Excerpt

As in the general population, obesity has become a health problem amongst human immunodeficiency virus (HIV) patients [1]. Its prevalence has increased since the beginning of the epidemic [2, 3] in developed countries but also in resource-limited settings [4]. HIV infection is associated with an increased risk of cardiovascular disease [5]. Moreover, adipose tissue may play a role in immune activation, acting as a viral reservoir [6]. In addition, treatment with combined antiretroviral therapy (cART) has been associated with weight gain and multiple metabolic problems such as dyslipidemia, lipodystrophy, insulin resistance, and increased risk of vascular disease [7‐9]. Compared to normal weight HIV patients receiving cART, obese patients experience a smaller rise in CD4 cell counts [3]. …
Literature
1.
Thompson-Paul AM, Wei SC, Mattson CL, et al. Obesity among HIV-infected adults receiving medical care in the United States: data from the cross-sectional Medical Monitoring Project and National Health and Nutrition Examination Survey. Medicine (Baltimore) [Internet]. 2015 [cited 9 June 2016];94(27)
2.
Crum-Cianflone N, Roediger MP, Eberly L, et al. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One. 2010;5:e10106.CrossRefPubMedPubMedCentral
3.
Pourcher G, Costagliola D, Martinez V. Obesity in HIV-infected patients in France: forme prevalence and surgical treatment options. Journal of Visceral Surgery. 2015;152:33–7.CrossRefPubMed
4.
Guehi C, Badjé A, Gabillard D, et al. High prevalence of being overweight and obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Res Ther. 2016;13:12.CrossRefPubMedPubMedCentral
5.
Anne-Lise P, Chang C-CH, So-Armah KA, et al. Human immunodeficiency virus infection, cardiovascular risk factor profile and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 2015;68(2):209–16.CrossRefPubMedCentral
6.
Damouche A, Lazure T, Avettand-Fènoël V, et al. Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PLoS Pathog. 2015;11(9):e1005153.CrossRefPubMedPubMedCentral
7.
Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1223–30.CrossRefPubMed
8.
Montessori V, Press N, Harris M, et al. Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc J. 2004;170:229–38.
9.
Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328.CrossRefPubMed
10.
Fysekidis M, Cohen R, Bekheit M, et al. Sleeve gastrectomy is a safe and efficient procedure in HIV patients with morbid obesity: a case series with results in weight loss, comorbidity evolution, CD4 count, and viral load. Obes Surg. 2015;25(2):229–33.CrossRefPubMed
11.
Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:CD003641.
12.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefPubMed
13.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRefPubMedPubMedCentral
14.
Shor-Posner G, Campa A, Zhang G, et al. When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. J Acquir Immune Defic Syndr. 2000;23:81–8.CrossRefPubMed
15.
Razonable R, Estes L, Thompson G, et al. Gastric bypass surgery and serum concentrations of zidovudine, lamivudine, and nelfinavir. Presented at the International Conference on AIDS, 2002. p. 14
16.
Flancbaum L, Drake V, Colarusso T, et al. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Rel Dis. 2005;1:73–6.CrossRef
17.
Selke H, Norris S, Osterholzer D, et al. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDs. 2010;24(9):545–50.CrossRefPubMed
18.
Alfa-Wali M, Seechurn S, Ayodeji O, et al. Outcomes of bariatric surgery in HIV-positive individuals. Minerva Chir. 2016
19.
Zivich S, Cauterucci M, Allen S, et al. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obesity Research & Clinical Practice. 2015;9:633–5.CrossRef
20.
Tang A, Graham N, Chandra R, et al. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997;127:345–51.PubMed
21.
Eddy F, Elvin S, Sanmani L. Bariatric surgery. An HIV-positive patient’s successful journey, International Journal of STD & AIDS. 2015;0(0):1–2.
Metadata
Title
Feasibility of Bariatric Surgery in the HIV-Infected Patients
Authors
Radwan Kassir
Eve Huart
Olivier Tiffet
Anne Frésard
Fréderic Lucht
Amandine Gagneux-Brunon
Elisabeth Botelho-Nevers
Publication date
01-03-2017
Publisher
Springer US
Published in
Obesity Surgery / Issue 3/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2538-9

Other articles of this Issue 3/2017

Obesity Surgery 3/2017 Go to the issue

Original Contributions

Micronutrient Status in Morbidly Obese Patients Prior to Laparoscopic Sleeve Gastrectomy and Micronutrient Changes 5 years Post-surgery

Original Contributions

A Pilot Study on Telephone Cognitive Behavioral Therapy for Patients Six-Months Post-Bariatric Surgery

Original Contributions

Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism

Original Contributions

Project HELP: a Remotely Delivered Behavioral Intervention for Weight Regain after Bariatric Surgery

Original Contributions

What Is the Best Treatment before Bariatric Surgery? Exercise, Exercise and Group Therapy, or Conventional Waiting: a Randomized Controlled Trial

Letter to Editor/LED Reply

Response to Comment on: Systematic Review and Meta-Analysis of Occupational Outcomes After Bariatric Surgery